These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 4709445)
21. Trends in Mexican life insurance medicine. GarcĂa S Lebensversicher Med; 1980 Jul; 32(4):81-3. PubMed ID: 6110141 [No Abstract] [Full Text] [Related]
22. [Risk of epilepsy in life insurance]. Hofmann H Lebensversicher Med; 1986 Jan; 38(1):26-30. PubMed ID: 2869391 [No Abstract] [Full Text] [Related]
23. [Genome analysis--burdens, rights and responsibilities for using genetic knowledge]. Steinvorth U Z Gerontol Geriatr; 1995; 28(5):378-81. PubMed ID: 8528931 [No Abstract] [Full Text] [Related]
24. [Status and development in life insurance medicine in Belgium]. Jacobs E Lebensversicher Med; 1980 May; 32(3):57-60. PubMed ID: 6110134 [No Abstract] [Full Text] [Related]
25. [Pathogenesis and early diagnosis of multiple sclerosis with regard to the conditions of life insurance medicine]. Schrader A Lebensversicher Med; 1986 Jan; 38(1):11-5. PubMed ID: 2869387 [No Abstract] [Full Text] [Related]
26. Implications of genetic testing: discrimination in life insurance and future directions. Mould A J Law Med; 2003 May; 10(4):470-87. PubMed ID: 12852320 [TBL] [Abstract][Full Text] [Related]
27. The eligibility of syphilitic persons for life insurance. MOORE JE; SCHAMBERG IL J Am Med Assoc; 1947 Aug; 134(18):1532-5. PubMed ID: 20255629 [No Abstract] [Full Text] [Related]
28. [Insurance possibilities in tetraplegia and hemiplegia]. Hefti ML Lebensversicher Med; 1986 Jan; 38(1):15-22. PubMed ID: 2869388 [No Abstract] [Full Text] [Related]
29. Veterans' Group Life Insurance (VGLI) no-health period extension. Final rule. Department of Veterans Affairs Fed Regist; 2012 Nov; 77(212):66069-71. PubMed ID: 23139945 [TBL] [Abstract][Full Text] [Related]
30. Recent developments in health insurance, life insurance, and disability insurance case law. Hasman JJ; Chittenden WA; Doolin EG; Wall JF Tort Trial Insur Pract Law J; 2008; 43(3):473-517. PubMed ID: 18828249 [TBL] [Abstract][Full Text] [Related]
31. Life expectancy and insurability in heart disease. GUBNER RS; UNGERLEIDER HE Mod Concepts Cardiovasc Dis; 1959 Dec; 28():565-9. PubMed ID: 13829982 [No Abstract] [Full Text] [Related]
32. Adverse selection in the health care financing system. Archer RL Bests Rev Life Health Insur Ed; 1978 Oct; 79(6):10, 12, 87. PubMed ID: 10238975 [No Abstract] [Full Text] [Related]
33. Laboratory aids to risk selection. Donauer RM Trans Assoc Life Insur Med Dir Am; 1972; 55():149-71. PubMed ID: 5073111 [No Abstract] [Full Text] [Related]
34. Genetic information and life insurance risk classification and antiselection (1). Pokorski RJ J Insur Med; 1994-1995 Winter; 26(4):413-9. PubMed ID: 10150806 [No Abstract] [Full Text] [Related]
35. [Multiple sclerosis and its prognostic evaluation in life insurance]. Raestrup O Med Welt; 1967 Apr; 17():1075-81. PubMed ID: 5584465 [No Abstract] [Full Text] [Related]
36. [Life insurance medicine: insurance for risk of dying]. Bosch E Ned Tijdschr Geneeskd; 1993 Nov; 137(45):2306-10. PubMed ID: 8255336 [No Abstract] [Full Text] [Related]
37. [Prognosis of refused applicants for life insurance]. Stockmann H Lebensversicher Med; 1971 Jul; 23(4):78-84. PubMed ID: 4398052 [No Abstract] [Full Text] [Related]
38. [Duration of the human life, its influence on the life insurance and prevention of aging]. GOFFIN J Acta Med Scand Suppl; 1953; 277():381-90. PubMed ID: 13065049 [No Abstract] [Full Text] [Related]
39. [Duration of the human life, its influence on the life insurance and prevention of aging]. VOUTE PA Acta Med Scand Suppl; 1953; 277():269-91. PubMed ID: 13065046 [No Abstract] [Full Text] [Related]
40. [Duration of the human life; its influence on the life insurance and prevention of aging]. FIANDACA S Acta Med Scand Suppl; 1953; 277():292-373. PubMed ID: 13065047 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]